Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/25/2025

Treatment of Esophageal Candidiasis

Diagnosis

  • The patient's presentation is consistent with esophageal candidiasis, characterized by linear yellow to white plaques on esophageal mucosa seen on EGD, difficulty swallowing, and HIV infection, a major risk factor, as recommended by the Infectious Diseases Society of America 1
  • HIV infection is a major risk factor for esophageal candidiasis, as stated by the Centers for Disease Control and Prevention 1, 2

First-line Treatment

  • The American College of Physicians recommends oral fluconazole 200-400 mg daily for 14-21 days as the first-line treatment for esophageal candidiasis, with strong recommendation and high-quality evidence 1, 2, 3
  • Fluconazole is superior to ketoconazole and comparable to itraconazole solution, with most patients showing improvement within 7 days of starting therapy, as reported by the Infectious Diseases Society of America 3

Alternative Options

  • The Infectious Diseases Society of America recommends intravenous fluconazole 400 mg daily as an alternative option for patients who cannot tolerate oral therapy 1, 3
  • Echinocandins, such as micafungin, caspofungin, and anidulafungin, are effective alternative options for patients who cannot tolerate azoles, as stated by the Centers for Disease Control and Prevention 1, 3

Prevention of Recurrence

  • The Centers for Disease Control and Prevention recommends chronic suppressive therapy with fluconazole 100-200 mg three times weekly to prevent recurrence of esophageal candidiasis 1, 3
  • Antiretroviral therapy is strongly recommended to reduce recurrence risk, as reported by the MMWR Recommendations and Reports 4

Monitoring

  • The Infectious Diseases Society of America recommends assessing clinical response within 7 days and monitoring for adverse effects of fluconazole, including transaminase elevations, as stated by the Clinical Infectious Diseases journal 3, 4
  • Completing the full treatment course is essential, even if symptoms resolve quickly, as recommended by the American College of Physicians 3